A battery-powered vestibular stimulation system uses a controller to manage energy delivery through electrodes for user comfort.
Self-configuring intracardiac pacemakers detect far-field pacing pulses to coordinate dual chamber therapy without transvenous leads.
Implantable medical devices measure intracardiac impedance to detect local myocardial contraction timing across candidate electrode pairs.
A cardiac controller switches between primary and secondary pacing modes based on detected atrial-ventricular intervals.
A cardiac pacing system adjusts AV intervals using FIFO buffers to compute fusion timing.
Electrical neuromodulation at extravascular cardiac sites balances autonomic nerve activity to improve ventricular contractility.
Disposable pacemaker integrates pulse generator with secured pacing lead to reduce entanglement risks and improve patient mobility.
An adhesive film connects internal components without mounting frames, eliminating structural volume and material costs while maintaining mechanical stability.
A cardiac stimulation device alters the ejection profile to reduce blood pressure.
Segmented energy core and ingress-protective housing resolve the trade-off between impact resistance and component replacement in wearable cardiac devices.
A cardiac pacing relay switches electrodes between analog and digital lines to transmit pacing signals across high-density catheters.
Modulating the atrial escape interval exposes hidden ventricular depolarizations, preventing false mode commutations caused by safety window masking.
A medical device cycles electrical stimulation states to coordinate therapy delivery with MRI imaging sessions.
Intracorporeal electrodes measure tissue impedance to monitor visceral fat changes, resolving the trade-off between MRI precision and device complexity.
A ventricular pacing protocol promotes intrinsic conduction using truncated blanking periods and crosstalk management.
A cardiac rhythm management method measures RV-LV delay times to identify candidate left ventricular electrodes for pacing vector selection.
An implantable cardiac pacer uses an accelerometer sensor to detect phrenic nerve stimulation signals during pacing therapy.
Spatial analysis of distributed hemodynamic signals determines stability, preventing unnecessary high-energy anti-tachycardia therapies.